GCTK (GlucoTrack) EPS (Basic): $-18.04 (TTM As of Mar. 2026)


GCTK GlucoTrack Inc GCTK
19 GF Score
Price $0.34
! 2 Warning Signs
View Full Analysis

What is GlucoTrack EPS (Basic)?

GlucoTrack GCTK -2.80% 19 EPS (Basic) is $-18.04 as of Mar. 2026. GuruFocus rates GCTK with a GF Score™ of 19/100. The stock has 2 warning signs investors should review.

GlucoTrack's basic earnings per share (Basic EPS) for the three months ended in Mar. 2026 was $-2.65. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was $-18.04.

GlucoTrack's EPS (Diluted) for the three months ended in Mar. 2026 was $-2.65. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was $-18.04.

GlucoTrack's EPS without NRI for the three months ended in Mar. 2026 was $-2.57. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was -18.18.

During the past 3 years, the average EPS without NRI Growth Rate was 75.40% per year. During the past 5 years, the average EPS without NRI Growth Rate was 37.90% per year. During the past 10 years, the average EPS without NRI Growth Rate was 47.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, GlucoTrack's highest 3-Year average EPS without NRI Growth Rate was 79.60% per year. The lowest was -40.70% per year. And the median was 19.00% per year.

GlucoTrack  (NAS:GCTK) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

GlucoTrack EPS (Basic) Related Terms

GlucoTrack EPS (Basic) Historical Data

* Premium members only.

The historical data trend for GlucoTrack's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GlucoTrack EPS (Basic) Chart

GlucoTrack Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1,560.00 -1,740.00 -2,050.80 -4,106.00 -31.22

GlucoTrack Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -40.14 -9.62 -4.64 -1.13 -2.65
GCTK
19GF Score
GlucoTrack Inc GCTK
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

GlucoTrack EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

GlucoTrack's Basic EPS for the fiscal year that ended in Dec. 2025 is calculated as

Basic EPS (A: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-19.388-0)/0.621
=-31.22

GlucoTrack's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-4.334-0)/1.638
=-2.65

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-18.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of $-18.04 mean?
GlucoTrack (GCTK) has a EPS (Basic) of $-18.04 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on GlucoTrack and its competitors.
Is GlucoTrack's EPS (Basic) too high?
GlucoTrack's current EPS (Basic) is $-18.04. Overall, GlucoTrack has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does GlucoTrack's EPS (Basic) compare to RSCF and CBSC?
GlucoTrack's EPS (Basic) of $-18.04 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Medical Devices & Instruments company?
A good EPS (Basic) depends on the Medical Devices & Instruments industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on GlucoTrack and its competitors. GlucoTrack's current EPS (Basic) is $-18.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GlucoTrack stock overvalued right now?
GlucoTrack (GCTK) has a current EPS (Basic) of $-18.04. The current EPS (Basic) is $-18.04. GlucoTrack's overall GF Score™ is 19/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For GlucoTrack (GCTK), the current EPS (Basic) is $-18.04 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

GlucoTrack Business Description

Address 301 Route 17 North, Suite 800, Rutherford, NJ, USA, 07070
GlucoTrack Inc is a medical device company focused on the development of an implantable continuous blood glucose monitor (CBGM) for patients with Type 1 and Type 2 diabetes. The company is developing its Glucotrack CBGM system to provide continuous glucose monitoring using implantable sensor technology and is advancing the product through clinical studies and regulatory processes.
19GF Score

Get the complete analysis for GCTK

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.34
Price